CG0070 plus pembro shows promising efficacy in NMIBC unresponsive to BCG

Upfront [177Lu]Lu-PSMA-617 radioligand therapy prior to radical prostatectomy in men with HR PC

Complete biochemical response below 0.1 ng/ml predicts long-term therapy-free survival via PSMA-radioguided surgery

Diagnostic performance of 18F-rhPSMA-7.3 PET in newly diagnosed unfavourable intermediate to very high-risk prostate cancer

Pembro monotherapy for participants with BCG–unresponsive HR NMIBC shows anti-tumour activity

Digital rectal examination is not useful as a solitary screening tool for prostate cancer in young men

Single intensive screening intervention using PSA and Stockholm3 in combination might reduce prostate cancer mortality

Intravesical IO using durvalumab shows promising results for patients with high risk NMIBC after BCG failure

Surgical technique remains the most important factor associated with recovery of urinary continence after radical prostatectomy